Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

239.77
+0.41000.17%
Volume:348.42K
Turnover:84.10M
Market Cap:31.99B
PE:42.67
High:245.00
Open:242.60
Low:239.68
Close:239.36
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.51
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.63
PE(LYR):102.91

Loading ...

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

TIPRANKS
·
Jun 05

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-04

Reuters
·
Jun 04

Alnylam And Inceptive Form Strategic AI Collaboration To Accelerate Discovery Of RNAi Therapeutics

Reuters
·
Jun 04

Alnylam Commits Up to $2B to AI-Driven Therapeutic Innovation -- Company Talk

Dow Jones
·
Jun 04

Alnylam Collaboration Aims to Accelerate Timelines For Drug Discovery -- Company Talk

Dow Jones
·
Jun 04

Alnylam, Inceptive form strategic AI collaboration

TIPRANKS
·
Jun 04

Alnylam partners with Inceptive in AI-driven RNAi drug discovery deal worth up to $2 billion

Reuters
·
Jun 04

Alnylam Pharmaceuticals - Co and Inceptive Collaboration Valued at up to $2 Bln With $30 Mln Upfront

THOMSON REUTERS
·
Jun 04

Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of Rnai Therapeutics

THOMSON REUTERS
·
Jun 04

Alnylam director David E.I. Pyott disposes of USD 1.14 million in common shares

Reuters
·
Jun 04

Alnylam files Form 3 for director Benjamin Cravatt

Reuters
·
Jun 04

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Adding Scientific Depth Amid RNAi Pipeline Scrutiny

Simply Wall St.
·
May 29

Alnylam shareholders back executive pay in advisory vote at annual meeting

Reuters
·
May 28

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Insulet (PODD)

TIPRANKS
·
May 27

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake

Simply Wall St.
·
May 23

J.P. Morgan Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
May 20

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Alnylam Pharmaceuticals Inc : JP Morgan Resumes Coverage With Overweight Rating; Price Target $420

THOMSON REUTERS
·
May 20

Alnylam Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
May 19

Alnylam publishes 2025 corporate responsibility report

Reuters
·
May 19